Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN119263959B details cost-effective 1,2-cyclopentanedimethanol production. Enhances supply chain reliability and reduces manufacturing complexity for pharmaceutical intermediates.
Patent CN113636968B details a novel Ru-catalyzed route for 3-acylpyrroles. Discover cost-effective, scalable manufacturing for pharmaceutical intermediates.
Patent CN112675920B reveals a novel Ruthenium catalyst for efficient chiral alcohol synthesis. Discover cost reduction in pharmaceutical intermediate manufacturing and scalable production methods.
Advanced catalytic synthesis for Eltrombopag Olamine reduces costs and improves supply chain reliability for global pharmaceutical intermediates manufacturing partners.
Patent CN113636968B details a novel Ru-catalyzed route for 3-acylpyrroles, offering cost-effective and scalable manufacturing solutions for pharmaceutical supply chains.
Patent CN102351726A reveals a high-yield baclofen intermediate synthesis using ultrafine potassium carbonate, eliminating toxic solvents and cryogenic conditions for cost-effective manufacturing.
Patent CN112675920B reveals a novel monochiral ruthenium catalyst enabling efficient asymmetric hydrogenation and kinetic resolution for high-purity pharmaceutical intermediates.
Patent CN110724164B discloses novel 3-substituted spiro ligands achieving 99% ee. Enables cost-effective API intermediate manufacturing with high TON.
Patent CN111793017B reveals Ru-catalyzed asymmetric hydrogenation for lactam intermediates. Offers high purity, safety without hydrogen gas, and scalable pharma manufacturing solutions.
Patent CN112812122B reveals a novel oxidative method for producing beta-indole carbonyls and pyranoindoles with high yield and mild conditions for reliable supply.
Novel patent CN103992241A offers high-purity N-substituted phenyl glycine via hydrogenation. Reduces cost and improves supply chain reliability for anticoagulant intermediates.
Novel synthesis of Danshensu Isopropyl Ester via Darzens epoxidation ensures high purity and yield. Reliable supply chain partner for cardiovascular drug intermediates.
Patent CN110002952A reveals iridium-catalyzed transfer hydrogenation for high-purity alcohol synthesis. Offers significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN114014768A details a barium-free continuous flow synthesis for high-purity tranexamic acid, offering significant cost reduction in API manufacturing and enhanced supply chain safety.
Patent CN114920655A reveals a cost-effective nitration-fluorination-reduction route for high-purity 2-fluoro-3-trifluoromethylaniline, offering significant supply chain advantages.
Novel scalable route for tegoprazan key intermediate offering high purity ≥99% and simplified post-processing for reliable pharmaceutical supply chains.
Patent CN109678840B reveals normal pressure hydrogenation for high-purity pomalidomide. Reduces equipment costs and enhances supply chain reliability for pharmaceutical intermediates.
Patent CN101875658B details a chromatography-free route for spiro diazepine intermediates, offering significant cost reduction and scalable manufacturing advantages for pharmaceutical supply chains.
Patent CN107540678A reveals Pd-catalyzed CDC method for high-purity coumarin derivatives, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN116715699B reveals manganese-based asymmetric hydrogenation. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing.